Please login or register first to view this content.
Immune Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Efzofitimod Granted Orphan Drug Status for Systemic Sclerosis
FDA Extends Shelf Life of Immune Globulin Products Asceniv and Bivigam
Jergens Moisturizer Recalled Due to Bacteria Risk
Certain Immune Globulin Products Withdrawn Due to Higher Rate of Hypersensitivity Reactions
Lilly Ends Baricitinib Lupus Program, Provides Update on Atopic Dermatitis sNDA
Biosimilars Could Cut Spending for Biologic Therapy in the US
Novel Immunomodulator Gets Orphan Drug Status for Sarcoidosis
Orencia Approved for Prevention of Acute Graft Versus Host Disease
Cutaquig Approved for Pediatric Patients With Primary Humoral Immunodeficiency
October 2021: 5 Notable Drug Approvals
Doctors Report That Kidney Grown in Pig Worked in a Human
Potential Safety Concern for Guillain-Barré Syndrome ID’d for Ad26.COV2.S
Cudetaxestat Gets Orphan Drug Status for Systemic Sclerosis
Rethymic Approved for Pediatric Congenital Athymia
Tavneos Approved for ANCA-Associated Vasculitis
Jakafi Approved for Chronic Graft-vs-Host Disease
Ruzurgi Tablets Recalled Due to Yeast, Mold, Bacterial Contamination
mRNA COVID-19 Vaccines Immunogenic in Immunosuppressed Patients
